It uses CRISPR/Cas9 to make a patient’s haematopoietic stem cells produce high levels of foetal haemoglobin (HbF) in red blood cells, by introducing a gene known as BCL11A which down-regulates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback